Current findings on pleural effusion and ascites
ewimed Report 2025

The new ewimed Report 2025 – Current findings on pleural effusion and ascites
In this fourth issue, we present the latest scientific findings, well-founded expert opinions and practical case studies on the treatment of pleural effusion and ascites with a subcutaneously tunneled pleural or peritoneal indwelling catheter (IPC).
A key component of this year’s report is the analysis of data from the ewimed patient questionnaire 2024. ewimed has been collecting valuable information throughout Germany for 15 years now in order to further develop and improve treatment for patients in a targeted manner. In addition, the report presents a current scientific study on pleural effusion and highlights the latest developments in medical research.
Study conclusion: Fewer infections in non-malignant ascites
One particularly exciting article is dedicated to the topic of infections in non-malignant ascites. A recent study shows that silver-containing catheters can significantly reduce the risk of infection. This section is supplemented by an expert interview with Prof. Dr. Benjamin Maasoumy from Hannover Medical School, who explains the results of this study.
We have you in mind! Sustainability in the healthcare sector
There is also an increasing focus on sustainability in the healthcare sector. The ewimed Report 2025 provides an international perspective on this and presents initiatives from various countries.
In an expert discussion with PD Dr. med. Stefan Welter (Chief Physician of Thoracic Surgery at the Hemer Lung Clinic and Head of the “Sustainability in Thoracic Surgery” working group of the German Society for Thoracic Surgery) and Martina Moll (Senior Manager Sustainability at Sana Kliniken AG), we will discuss which sustainable measures clinics are already implementing and which challenges still exist.
Two case studies: Patients talk about their experiences with the IPC
📖 Download the ewimed Report 2025 as a PDF and gain valuable insights into current developments in the treatment of pleural effusion and ascites.
You haven’t read last year’s report yet?
Nothing found.